Gelonghui April 19 丨 Yifan Pharmaceutical (002019szabo'sarcade.SZ) Announces 2023 Annual Reportszabo'sarcade, operating income during the reporting period was 4.068 billion yuan, a year-on-year increase of 6.03%; net profit attributable to shareholders of listed companies was-551 million yuan, turning from profit to loss year-on-year; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was-533 million yuan; Basic earnings per share-0.45 yuan.